Advisor Group Holdings, Inc. Puma Biotechnology, Inc. Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,143 shares of PBYI stock, worth $3,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,143

Previous 977 16.99%

Holding current value

$3,177

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$2.42 - $3.39 $401 - $562	166 Added 16.99%	1,143 $3,000
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.83 $954 - $1,906	327 Added 50.31%	977 $3,000
Q1 2024 May 10, 2024	BUY	$4.29 - $7.4 $1,287 - $2,220	300 Added 85.71%	650 $3,000
Q4 2023 Feb 12, 2024	BUY	$2.23 - $4.49 $446 - $898	200 Added 133.33%	350 $1,000
Q3 2023 Nov 13, 2023	SELL	$2.63 - $4.09 $42,248 - $65,701	-16,064 Reduced 99.07%	150 $0
Q2 2023 Aug 10, 2023	SELL	$2.6 - $3.58 $1,890 - $2,602	-727 Reduced 4.29%	16,214 $57,000
Q1 2023 May 12, 2023	SELL	$2.21 - $4.82 $1,080 - $2,356	-489 Reduced 2.81%	16,941 $52,000
Q4 2022 Feb 10, 2023	SELL	$2.12 - $5.08 $110 - $264	-52 Reduced 0.3%	17,430 $73,000
Q3 2022 Nov 14, 2022	BUY	$2.27 - $3.84 $5,679 - $9,607	2,502 Added 16.7%	17,482 $42,000
Q2 2022 Aug 10, 2022	SELL	$1.64 - $3.3 $459 - $924	-280 Reduced 1.83%	14,980 $42,000
Q1 2022 May 04, 2022	SELL	$2.13 - $3.24 $29,732 - $45,227	-13,959 Reduced 47.77%	15,260 $33,000
Q3 2021 Nov 05, 2021	BUY	$6.63 - $9.39 $97,076 - $137,488	14,642 Added 100.45%	29,219 $196,000
Q2 2021 Aug 02, 2021	BUY	$8.98 - $11.6 $13,622 - $17,597	1,517 Added 11.62%	14,577 $134,000
Q1 2021 May 13, 2021	BUY	$9.38 - $13.63 $8,629 - $12,539	920 Added 7.58%	13,060 $127,000
Q4 2020 Feb 10, 2021	SELL	$7.78 - $12.13 $18,438 - $28,748	-2,370 Reduced 16.33%	12,140 $124,000
Q3 2020 Nov 12, 2020	BUY	$9.5 - $11.14 $39,472 - $46,286	4,155 Added 40.13%	14,510 $147,000
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $5,713 - $10,790	815 Added 8.54%	10,355 $108,000
Q1 2020 May 18, 2020	BUY	$6.28 - $14.57 $59,911 - $138,997	9,540 New	9,540 $80,000

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29.2M

Call Options Held

60.6K

Put Options Held

16.3K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $127M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Puma Biotechnology, Inc. Transaction History